The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 8.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 36% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 147%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (6 analysts) rates it strong buy, with a mean price target of $86.
Helios Technologies, Inc.
HLIO · the NYSE · USD · Market cap $2.5B · 2,300 employees
Helios Technologies, Inc., together with its subsidiaries, provides engineered motion control and electronic controls technology solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
PASS · Titan Ethical · score 70.0At the last full screen
2026-08-27
Screened 2026-08-27 · the tape above runs as of 10:31 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
Helios Technologies, Inc. holds its Markdown at $74.43. Consolidating, no directional conviction, held for 10 days.
| Phase | Markdown · caution |
| Quantitative state | Consolidating, no directional conviction, held for 10 days |
| Price at the screen | $74.43 |
| Valuation | 34.78 trailing · 20.76 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 1.27 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 24.24% | Below 33% | Interest-bearing debt is just 24.2% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 12.48% | Below 49% | Money owed to the company is 12.5% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.00% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-08-27 screen. The gold marker is the market price at the same screen. A 10.3% margin of safety to the base estimate.
Third-party analyst targets: 6 covering, consensus Strong Buy. The average target sits +24% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-08-27 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsHydraulics Maker Priced Beyond Its True Value
Picture a factory floor where hydraulic valves keep heavy equipment moving without fuss. Helios Technologies supplies those components across two divisions, yet its shares sit 5 percent above our fair value with a forward multiple of 24 times and returns on equity stuck at just 7 percent. Revenue growth of 17 percent looks decent on paper but fails to offset thin profit margins of 7 percent and an unknown competitive edge.
We pass because the valuation leaves no margin of safety and the numbers do not support paying up. Six analysts see a median target only modestly higher while the business earns low returns in a competitive industrial niche.
Industrial cycles can flatten earnings quickly, and the current multiple already prices in optimism that may not materialise. The ethical screen clears, yet the price and returns still give no reason to step in. Analysis, not advice.
| Forward P/E | 20.8xexpensive even after accounting for its growth |
| Trailing P/E | 34.8xa premium valuation |
| EPS, trailing | 2.14 |
| EPS, forward | 3.59 |
| Revenue growth | +9.1%steady growth |
| Profit margin | 8.0%thin but positive margins |
| Return on equity | 7.7%a modest return on shareholder capital |
| FCF yield | 4.83% |
| Dividend yield | 57.00% |
| Debt to equity | 0.37minimal debt: a conservative balance sheet |
| Current ratio | 2.74comfortably covers its short-term bills |
| Beta | 1.27moves a little more than the market |
| Short interest, float | 0.03% |
| 52-week range | 47.01 - 95.05 |
| Market cap | $2.5B |
| Employees | 2,300 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeHLIO trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 4.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 36% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 147%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (6 analysts) rates it strong buy, with a mean price target of $86.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 36% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 147%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (6 analysts) rates it strong buy, with a mean price target of $86.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $68.02 | +19.2% | · | $1,192 | +19.2% |
| 2 months | $71.01 | +14.2% | $0.12 | $1,143 | +14.3% |
| 3 months | $65.62 | +23.5% | $0.12 | $1,237 | +23.7% |
| 6 months | $57.32 | +41.4% | $0.21 | $1,418 | +41.8% |
| 1 year | $32.86 | +146.7% | $0.39 | $2,478 | +147.8% |
| 2 years | $46.93 | +72.7% | $0.75 | $1,743 | +74.3% |
| 3 years | $60.93 | +33.0% | $1.11 | $1,349 | +34.9% |
| 5 years | $70.22 | +15.4% | $1.83 | $1,180 | +18.0% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever HLIO does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.